1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

Term ID

CHEBI:78264

Synonyms

(2S,8R,13Z,16Z,19Z,22Z,25Z,28Z)-2-azaniumyl-8-{[(1Z)-octadec-1-en-1-yloxy]methyl}-5-oxido-10-oxo-4,6,9-trioxa-5-phosphahentriaconta-13,16,19,22,25,28-hexaen-1-oate 5-oxide
1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-L-serine
1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphoserine(1-)

Definition

A 1-(1Z-alkenyl)-2-acyl-sn-glycero-3-phospho-L-serine(1-) in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

PMID:23071296

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1-(1Z-alkenyl)-2-acyl-sn-glycero-3-phospho-L-serine(1-)

1-(1Z-alkenyl)-2-acyl-sn-glycero-3-phospho-L-serine(1-) Show first 5 Terms
inverse is_conjugate_acid_of: 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine

1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine Show first 5 Terms
is_conjugate_base_of: 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine

1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine Show first 5 Terms

Phenotype

Phenotype resulting from 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

Phenotype where environments contain 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

Phenotype modified by environments containing 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

Human Disease Model